MOUNJARO 15 mg/.5mL (Tirzepatide INJECTION, SOLUTION) 15 mg/.5mL

MOUNJARO 15 mg/.5mL is a subcutaneous injection solution containing tirzepatide. This medication is used for managing weight and improving glycemic control in adults with type 2 diabetes. Discover its uses, effects, and precautions here.

Strength

15 mg/.5mL

Pack Size

4 SYRINGE in 1 CARTON (0002-1457-80) / .5 mL in 1 SYRINGE (0002-1457-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MOUNJARO 15 mg/.5mL is primarily used for weight management and glycemic control in adults with type 2 diabetes. Tirzepatide, the active ingredient, works by regulating appetite and blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. Understanding what tirzepatide is used for can help individuals make informed decisions about their health.

Side Effects

Common effects of MOUNJARO 15 mg/.5mL may include nausea, diarrhea, and injection site reactions. Some users may experience changes in appetite and weight loss. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent. Individual responses to tirzepatide can vary, so it's essential to follow the prescribed regimen closely.

Precautions & Warnings

MOUNJARO 15 mg/.5mL should be stored at room temperature and protected from light. It is crucial to use the medication as directed and not to share syringes. Individuals with a history of pancreatitis or severe gastrointestinal disease should discuss their medical history with a healthcare provider before starting tirzepatide. Always follow the prescribed dosage and administration guidelines.

Avoid Interactions

MOUNJARO 15 mg/.5mL may interact with other medications, including insulin and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels. Certain CYP inhibitors may also interact with tirzepatide, so it's important to inform your healthcare provider about all medications you are taking. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

MOUNJARO 15 mg/.5mL is used for weight management and glycemic control in adults with type 2 diabetes.

MOUNJARO 15 mg/.5mL is administered via subcutaneous injection. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, and injection site reactions. Consult a healthcare provider if these effects are severe.

MOUNJARO 15 mg/.5mL may interact with other medications, including insulin and diabetes drugs. Always consult a healthcare provider before combining medications.

MOUNJARO 15 mg/.5mL should be stored at room temperature and protected from light. Follow the storage instructions provided with the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.